Aptevo Therapeutics (APVO) Change in Receivables (2015 - 2019)

Aptevo Therapeutics (APVO) posted Change in Receivables of -$896000.0 for Q4 2019, down 265.93% sequentially from $540000.0 in Q3 2019.

Aptevo Therapeutics (APVO) Change in Receivables (2015 - 2019) Analysis & Trends

Aptevo Therapeutics has reported Change in Receivables for 5 years, with the latest figure at -$896000.0 in Q4 2019.

Quarterly Change in Receivables changed N/A year-over-year to -$896000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $1.8 million (changed N/A YoY) and the FY2019 annual result came in at $1.8 million, down 41.47% from the prior year.
Change in Receivables declined to -$896000.0 in Q4 2019 per APVO's latest filing, from $540000.0 in the prior quarter.
Over five years, Change in Receivables peaked at $5.1 million in Q2 2016 and troughed at -$5.9 million in Q4 2015.
A 5-year average of $330117.6 and a median of $957000.0 in 2018 frame the typical range for Change in Receivables.
The sharpest annual moves came in 2016 and 2018: Change in Receivables sank 657.73% in 2016, then soared 878.05% in 2018.
Over 5 years, Change in Receivables stood at -$5.9 million in 2015, then jumped by 122.57% to $1.3 million in 2016, then climbed by 21.74% to $1.6 million in 2017, then jumped by 151.77% to $4.1 million in 2018, then plunged by 122.06% to -$896000.0 in 2019.
According to Business Quant data, Change in Receivables over the past three periods registered -$896000.0, $540000.0, and $1.6 million for Q4 2019, Q3 2019, and Q2 2019 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	140.20 Mn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	838.50 Mn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-53.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	117.58 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	31.60 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	94.29 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	37.16 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Aptevo Therapeutics	3.18 Mn	-6.61 Mn	-	-

Download Data